BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 29241728)

  • 1. An actin cytoskeletal barrier inhibits lytic granule release from natural killer cells in patients with Chediak-Higashi syndrome.
    Gil-Krzewska A; Saeed MB; Oszmiana A; Fischer ER; Lagrue K; Gahl WA; Introne WJ; Coligan JE; Davis DM; Krzewski K
    J Allergy Clin Immunol; 2018 Sep; 142(3):914-927.e6. PubMed ID: 29241728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chediak-Higashi syndrome: Lysosomal trafficking regulator domains regulate exocytosis of lytic granules but not cytokine secretion by natural killer cells.
    Gil-Krzewska A; Wood SM; Murakami Y; Nguyen V; Chiang SCC; Cullinane AR; Peruzzi G; Gahl WA; Coligan JE; Introne WJ; Bryceson YT; Krzewski K
    J Allergy Clin Immunol; 2016 Apr; 137(4):1165-1177. PubMed ID: 26478006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LYST controls the biogenesis of the endosomal compartment required for secretory lysosome function.
    Sepulveda FE; Burgess A; Heiligenstein X; Goudin N; Ménager MM; Romao M; Côte M; Mahlaoui N; Fischer A; Raposo G; Ménasché G; de Saint Basile G
    Traffic; 2015 Feb; 16(2):191-203. PubMed ID: 25425525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in Granule Morphology yet Equally Impaired Exocytosis among Cytotoxic T Cells and NK Cells from Chediak-Higashi Syndrome Patients.
    Chiang SCC; Wood SM; Tesi B; Akar HH; Al-Herz W; Ammann S; Belen FB; Caliskan U; Kaya Z; Lehmberg K; Patiroglu T; Tokgoz H; Ünüvar A; Introne WJ; Henter JI; Nordenskjöld M; Ljunggren HG; Meeths M; Ehl S; Krzewski K; Bryceson YT
    Front Immunol; 2017; 8():426. PubMed ID: 28458669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis.
    Baetz K; Isaaz S; Griffiths GM
    J Immunol; 1995 Jun; 154(11):6122-31. PubMed ID: 7751653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
    Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR
    J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell effector functions in a Chédiak-Higashi patient undergoing cord blood transplantation: Effects of in vitro treatment with IL-2.
    Cifaldi L; Pinto RM; Rana I; Caniglia M; Angioni A; Petrocchi S; Cancrini C; Cursi L; Palumbo G; Zingoni A; Gismondi A; Rossi P; Santoni A; Cerboni C
    Immunol Lett; 2016 Dec; 180():46-53. PubMed ID: 27816481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "lazy" NK cells of Chediak-Higashi syndrome.
    Targan SR; Oseas R
    J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chediak-Higashi syndrome.
    Talbert ML; Malicdan MCV; Introne WJ
    Curr Opin Hematol; 2023 Jul; 30(4):144-151. PubMed ID: 37254856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay.
    Katz P; Zaytoun AM; Fauci AS
    J Clin Invest; 1982 Jun; 69(6):1231-8. PubMed ID: 6177715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lytic granules, secretory lysosomes and disease.
    Clark R; Griffiths GM
    Curr Opin Immunol; 2003 Oct; 15(5):516-21. PubMed ID: 14499259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and functional analysis of beige (Chèdiak-Higashi syndrome) mouse mast cells with giant granules.
    Kiyoi T; Liu S; Sahid MNA; Shudou M; Ogasawara M; Mogi M; Maeyama K
    Int Immunopharmacol; 2019 Apr; 69():202-212. PubMed ID: 30738290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiency of inducible suppressor cell activity in the Chediak-Higashi syndrome.
    Nair MP; Gray RH; Boxer LA; Schwartz SA
    Am J Hematol; 1987 Sep; 26(1):55-66. PubMed ID: 2443005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal Trafficking Regulator (LYST).
    Ji X; Chang B; Naggert JK; Nishina PM
    Adv Exp Med Biol; 2016; 854():745-50. PubMed ID: 26427484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells].
    Wang J; Liu Z; Jiang LP; An YF; Zhao XD
    Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of Chediak Higashi disease in a 67-year old woman.
    Yarnell DS; Roney JC; Teixeira C; Freitas MI; Cipriano A; Leuschner P; Krzewski K; Stephen J; Dorward H; Gahl WA; Gochuico BR; Toro C; Malicdan MC; Introne WJ
    Am J Med Genet A; 2020 Dec; 182(12):3007-3013. PubMed ID: 32990340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nature of natural killer cell hyporesponsiveness in the Chediak-Higashi syndrome.
    Brahmi Z
    Hum Immunol; 1983 Jan; 6(1):45-52. PubMed ID: 6219972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and outcomes of chédiak-Higashi syndrome: a nationwide survey of Japan.
    Nagai K; Ochi F; Terui K; Maeda M; Ohga S; Kanegane H; Kitoh T; Kogawa K; Suzuki N; Ohta S; Ishida Y; Okamura T; Wakiguchi H; Yasukawa M; Ishii E
    Pediatr Blood Cancer; 2013 Oct; 60(10):1582-6. PubMed ID: 23804531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UNC-45A Is a Nonmuscle Myosin IIA Chaperone Required for NK Cell Cytotoxicity via Control of Lytic Granule Secretion.
    Iizuka Y; Cichocki F; Sieben A; Sforza F; Karim R; Coughlin K; Isaksson Vogel R; Gavioli R; McCullar V; Lenvik T; Lee M; Miller J; Bazzaro M
    J Immunol; 2015 Nov; 195(10):4760-70. PubMed ID: 26438524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of primary human cytotoxic T-cell and natural killer cell responses reveal similar molecular requirements for lytic granule exocytosis but differences in cytokine production.
    Chiang SC; Theorell J; Entesarian M; Meeths M; Mastafa M; Al-Herz W; Frisk P; Gilmour KC; Ifversen M; Langenskiöld C; Machaczka M; Naqvi A; Payne J; Perez-Martinez A; Sabel M; Unal E; Unal S; Winiarski J; Nordenskjöld M; Ljunggren HG; Henter JI; Bryceson YT
    Blood; 2013 Feb; 121(8):1345-56. PubMed ID: 23287865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.